Fingerprint
Dive into the research topics of 'A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer
Meng Zhao, Xueliang Pan, Rachel Layman, Maryam B. Lustberg, Ewa Mrozek, Erin R. Macrae, Robert Wesolowski, Sarah Carothers, Shannon Puhalla, Charles L. Shapiro, Bhuvaneswari Ramaswamy
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations